264. Blastomycosis in Children: An analysis of the clinical, epidemiologic, and genetic features
Session: Poster Abstract Session: Endemic Mycosis
Thursday, October 8, 2015
Room: Poster Hall
  • HollyFrost_BlastomycosisinChildren_Poster_IDWeek2015.pdf (116.1 kB)
  • Background: Blastomyces sp. is endemic in many regions of the United States and results in blastomycosis, a serious and potentially fatal infection. Little is known about the presentation, clinic course, environmental exposures, and genetics of this organism in children.

    Methods: A retrospective chart review of children with confirmed blastomycosis from 1999-2014 was completed and state epidemiologic data from this time period were analyzed. Blastomyces isolates from children were genotyped using microsatellite typing and species typed by sequencing of the internal transcribed spacer 2 (its2).

    Results: A total of 114 children with confirmed blastomycosis were identified; 79% of children had isolated pulmonary involvement and 21% had extra pulmonary disease. Children with isolated pulmonary disease had increased systemic findings including fever (p=0.01), poor oral intake (p=0.01), elevated WBC (p<0.01), and elevated CRP (p<0.01). Children with extra pulmonary disease had increased need for surgery (p=0.01) and delays in diagnosis (p<0.01). Of 52 samples genotyped, 48 (92%) children had B. gilchristii infections, which differs significantly from adults. Microsatellite group assignment and its2 species sequencing showed completed correlation with Group1 being equivalent to B. gilchristii and Group 2 equivalent to B. dermatitidis. .

    Conclusion: This is the first large scale study of the clinical, epidemiologic, and genetic features of blastomycosis in children. The majority of children had isolated pulmonary disease with systemic findings. Patients with extra pulmonary disease were less likely to have systemic symptoms or additional laboratory evidence of infection making delays in diagnosis more common. Over 90% of pediatric cases were caused by B. gilchristii.

    Holly Frost, MD1,2, Jennifer Meece, PhD3, Jennifer Anderson, .2 and Lynn Ivacic, .2, (1)Marshfield Clinic, Minocqua, WI, (2)Marshfield Clinic Research Foundation, Marshfield, WI, (3)Integrated Research and Diagnositic Laboratory, Marshfield Clinic Research Foundation, Marshfield, WI


    H. Frost, None

    J. Meece, None

    J. Anderson, None

    L. Ivacic, None

    See more of: Endemic Mycosis
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.